Artivion (AORT) SVP Andrew Green Sells $911K of Stock
Andrew Green, SVP at AORT, sold 44,001 shares on June 11, 2026, in a planned sale.
Reviewed by automated data checks against the source filing. How we make and check alerts
Andrew Green, SVP, Regulatory and Quality at Artivion, Inc. ($AORT), sold 44,001 shares at an average price of $20.70, worth about $910,662.30, on June 11, 2026. The trade was reported to the SEC in a Form 4 filing and was made under a pre-arranged Rule 10b5-1 trading plan.
Since the trade, $AORT is up 2.9% after 1 week, up 16.6% after 1 month and up 5.7% to date (from the $20.60 close on Jun 11, 2026).
AORT
Artivion, Inc.
Key Points
- Andrew Green, SVP of Regulatory and Quality at AORT, sold 44,001 shares on June 11, 2026, at an average price of $20.70, totaling $910,662.
- Shares of AORT traded near $20.35, with active institutional interest from peers like BlackRock and FMR LLC.
- Analysts have maintained a positive outlook on AORT, with firms like Citizens and Needham reiterating 'buy' ratings and targets up to $58.
Get $AORT trade alerts by text
We text you when insiders, Congress or big funds trade $AORT. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Artivion, Inc. alert may contain errors. Disclosures
Andrew Green, Senior Vice President of Regulatory and Quality at AORT, sold 44,001 shares of the company on June 11, 2026. This planned transaction was executed at an average price of $20.70 per share, amounting to approximately $910,662.
Other Institutional Activity in AORT
Several institutional investors have been active in AORT recently. BlackRock, Inc. increased its holdings by 106,735 shares, bringing its total to 6,474,854 shares valued at about $237.1 million. FMR LLC also added 41,560 shares, ending with 2,583,427 shares worth around $94.6 million. Meanwhile, Nomura Asset Management International Inc. reduced its position by 157,325 shares, holding 2,456,146 shares valued at $89.9 million. Morgan Stanley added 12,552 shares, totaling 2,269,294 shares worth $83.1 million. Vanguard Capital Management LLC initiated a position with 1,952,008 shares valued at $71.5 million.
Artivion, Inc. Stock Down 12.8%
Shares of AORT were trading near $20.35 recently. The company has attracted significant institutional interest, as evidenced by recent activities from major funds.
Insider Buying and Selling at Artivion, Inc.
Alongside Andrew Green's sale, other notable insider activity includes Anthony Semedo, who executed several transactions in May and June 2026. On June 2, Semedo sold 6,325 shares, while on May 18, he bought 7,576 shares.
Analysts Set New Price Targets
Analysts have shown a strong interest in AORT. On May 8, 2026, Citizens maintained a 'buy' rating with a $48 target, while Needham upheld its 'buy' rating with a $44 target. Earlier, on April 10, 2026, Ladenburg Thalmann upgraded AORT to a 'buy' with a $42 target.
Bottom Line
Andrew Green's recent sale of AORT shares is part of a planned transaction, reflecting ongoing insider activity. Investors often track such moves closely to gauge insider sentiment. Institutional investors have shown varied interest, with some increasing their stakes. Analyst sentiment remains positive, with multiple firms maintaining or upgrading their ratings. As always, these insights are based on past filings and may not reflect current positions.
Related Filing Alerts
Source: Andrew Green's Form 4 filing on $AORT (Jun 11, 2026). Find the original filing: AORT Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts